Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

930.60

1.75 (0.19%)

< Home < Back

Cadila Healthcare informs about Press release

Date: 11-08-2015

Cadila Healthcare has informed about a Press Release dated August 11, 2015 titled ‘Zydus receives final approval for Amiloride Hcl Tablets’.

The above information is a part of company’s filings submitted to BSE.